EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Extended HPV typing as an efficient alternative within HPV ‐based screening programs

Joacim Meneses-León iD, Berenice Rivera-Paredez iD, Sonia Hernández-Salazar iD, Leticia Torres-Ibarra iD, Martha Carnalla iD, Leith León-Maldonado iD, Rubí Hernández-López iD, José Damián Cadena-Fiscal iD, Anna B Moscicki iD, Manuel Quiterio-Trenado iD, Eduardo Lazcano-Ponce iD, Jorge Salmerón iD

International Journal of Cancer · 01.08.2026 · 159 (3) · 638-644

DOI: 10.1002/ijc.70428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 28.03.2026. Verfasst von Joacim Meneses-León und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Center in Policy, Population, and Health, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico. Hauptthemen laut MEDLINE: Early Detection of Cancer, Human Papillomavirus Viruses, Papillomavirus Infections, Uterine Cervical Dysplasia. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto Nacional de las Mujeres, Consejo Nacional de Ciencia y Tecnología, Coordinación de Investigación en Salud del Instituto Mexicano del Seguro Social.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extended high‐risk human papilloma virus (hrHPV) typing emerges as a potential alternative for detecting cervical intraepithelial neoplasia 3 (CIN3), without additional triage tests. We evaluate the extended hrHPV typing as an alternative to improve CIN3 detection within an HPV‐based screening program. Between January 2017 and August 2018, 5856 women aged 25–65 years were screened as part of a public cervical cancer screening program of the Tlalpan Sanitary Jurisdiction in Mexico City. HPV testing was performed by BD Onclarity™, which individually detects hrHPV types 16, 18, 31, 45, 51, and 52, and pools of types 33/58, 56/59/66, and 35/39/68. Specific hrHPV types within these pools were further identified using the Atila AmpFire platform. All HPV‐positive women ( n = 691) were referred to colposcopy evaluation for diagnostic confirmation. Of these, 561 women completed both colposcopy and histological confirmation, representing our analytical sample. HPV‐16 alone had a sensitivity of 43.0% and specificity of 85.4% for CIN3 detection. Sequentially adding HPV‐18/33/31/39 increased sensitivity to 100% for CIN3 detection, although with lower specificity (54.5%). The proportion of HPV‐16/18/33/31/39 positive women was 47.0%, with a CIN3 PPV 5.3%. Extended genotyping with HPV‐16/18/33/31/39 achieved 100% sensitivity for CIN3 detection, but a moderate specificity. This strategy aligns with the international recommendation for colposcopy referral in women with a PPV of CIN3 larger than 4.0%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerHuman Papillomavirus VirusesPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsAdultAgedFemaleHumansMiddle AgedColposcopyDNA, ViralGenotypeMass ScreeningMexicoSensitivity and Specificity

Stichwörter der Autor:innen

HPVHPV‐based screening programextended typingtriage

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Research Center in Policy, Population, and Health, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Center for Population Health Research, National Institute for Public Health, Cuernavaca, Mexico.
  • Oficina de Análisis del Plan de Salud, Subgerencia Técnica del Plan de Salud, Gerencia de Administración del Plan de Salud, Banco de México, Ciudad de México, Mexico.
  • Department of Systems, Statistics, Informatics and Information Analysis, Sanitary Jurisdiction, Mexico City, Mexico.
  • Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Department of Cancer Epidemiology, Center for Population Health Research, Institute for Public Health, Cuernavaca, Mexico.

ORCID-Profile: Joacim Meneses-León, Berenice Rivera-Paredez, Sonia Hernández-Salazar, Leticia Torres-Ibarra, Martha Carnalla, Leith León-Maldonado, Rubí Hernández-López, José Damián Cadena-Fiscal, Anna B Moscicki, Manuel Quiterio-Trenado, Eduardo Lazcano-Ponce, Jorge Salmerón

Förderung

  • Instituto Nacional de las Mujeres
  • Consejo Nacional de Ciencia y Tecnología
  • Coordinación de Investigación en Salud del Instituto Mexicano del Seguro Social
  • Secretaría de Salud Tlaxcala
  • National Institute of Public Health of Mexico
  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación

Zitieren

APA

Meneses-León, J., Rivera-Paredez, B., Hernández-Salazar, S., Torres-Ibarra, L., Carnalla, M., León-Maldonado, L., Hernández-López, R., Cadena-Fiscal, J. D., Moscicki, A. B., Quiterio-Trenado, M., Lazcano-Ponce, E., & Salmerón, J. (2026). Extended HPV typing as an efficient alternative within HPV ‐based screening programs. International Journal of Cancer, 159(3), 638-644. https://doi.org/10.1002/ijc.70428

Vancouver

Meneses-León J, Rivera-Paredez B, Hernández-Salazar S, Torres-Ibarra L, Carnalla M, León-Maldonado L, et al. Extended HPV typing as an efficient alternative within HPV ‐based screening programs. International Journal of Cancer. 2026;159(3):638-644. doi:10.1002/ijc.70428

BibTeX
@article{MenesesLen2026,
  author = {Meneses-León, Joacim and Rivera-Paredez, Berenice and Hernández-Salazar, Sonia and Torres-Ibarra, Leticia and Carnalla, Martha and León-Maldonado, Leith and Hernández-López, Rubí and Cadena-Fiscal, José Damián and Moscicki, Anna B and Quiterio-Trenado, Manuel and Lazcano-Ponce, Eduardo and Salmerón, Jorge},
  title = {Extended HPV typing as an efficient alternative within HPV ‐based screening programs},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {3},
  pages = {638--644},
  doi = {10.1002/ijc.70428}
}
Kostenlos starten →